Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group.

导出 LinkOut

翻译打印收藏纠错

作者： F A,Shepherd ^[1] ; J,Dancey ; A,Arnold ; A,Neville ; J,Rusthoven ; R D,Johnson ; B,Fisher ; E,Eisenhauer

作者单位： The Department of Medical Oncology and Hematology, Princess Margaret Hospital, 610 University Avenue, 5-104, Toronto, Ontario, M5G 2M9, Canada. frances.shepherd@uhn.on.ca ^[1]

主题词成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);顺铂(Cisplatin);女(雌)性(Female);叶酸拮抗剂(Folic Acid Antagonists);谷氨酸盐类(Glutamates);鸟嘌呤(Guanine);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);存活率分析(Survival Analysis);治疗结果(Treatment Outcome)

DOI 10.1002/1097-0142(20010801)92:3<595::aid-cncr1359>3.0.co;2-d

PMID 11505404

发布时间 2019-06-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览20

Cancer

2001年92卷3期

595-600页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group.

Cancer

相似文献

Cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group.

Cancer

相似文献

Cancer

相关期刊

检索历史清除